{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:35:28Z","timestamp":1790217328238,"version":"4.1.0"},"reference-count":184,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019586","name":"Arturo Prat University","doi-asserted-by":"publisher","award":["no"],"award-info":[{"award-number":["no"]}],"id":[{"id":"10.13039\/501100019586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The pathophysiology of pulmonary hypertension is complex and multifactorial. It is a disease characterized by increased pulmonary vascular resistance at the level due to sustained vasoconstriction and remodeling of the pulmonary arteries, which triggers an increase in the mean pulmonary artery pressure and subsequent right ventricular hypertrophy, which in some cases can cause right heart failure. Hypoxic pulmonary hypertension (HPH) is currently classified into Group 3 of the five different groups of pulmonary hypertensions, which are determined according to the cause of the disease. HPH mainly develops as a product of lung diseases, among the most prevalent causes of obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), or hypobaric hypoxia due to exposure to high altitudes. Additionally, cardiometabolic risk factors converge on molecular mechanisms involving overactivation of the mammalian target of rapamycin (mTOR), which correspond to a central axis in the development of HPH. The aim of this review is to summarize the role of mTOR in the development of HPH associated with metabolic risk factors and its therapeutic alternatives, which will be discussed in this review.<\/jats:p>","DOI":"10.3390\/ijms252011023","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:02:58Z","timestamp":1728878578000},"page":"11023","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors"],"prefix":"10.3390","volume":"25","author":[{"given":"Karen","family":"Flores","sequence":"first","affiliation":[{"name":"High Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Almeida","sequence":"additional","affiliation":[{"name":"High Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem","family":"Arriaza","sequence":"additional","affiliation":[{"name":"High Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2664-1722","authenticated-orcid":false,"given":"Eduardo","family":"Pena","sequence":"additional","affiliation":[{"name":"High Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7501-5077","authenticated-orcid":false,"given":"Samia","family":"El Alam","sequence":"additional","affiliation":[{"name":"High Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"H702","DOI":"10.1152\/ajpheart.00021.2022","article-title":"Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies","volume":"322","author":"Christou","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ghofrani, H.A., Gomberg-Maitland, M., Zhao, L., and Grimminger, F. (Nat. Rev. Cardiol., 2024). Mechanisms and treatment of pulmonary arterial hypertension, Nat. Rev. Cardiol., Epub ahead of print.","DOI":"10.1038\/s41569-024-01064-4"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1874192401610010019","article-title":"High-altitude Pulmonary Hypertension: An Update on Disease Pathogenesis and Management","volume":"10","author":"Mirrakhimov","year":"2016","journal-title":"Open Cardiovasc. Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/ham.2005.6.147","article-title":"Consensus statement on chronic and subacute high altitude diseases","volume":"6","author":"Maggiorini","year":"2005","journal-title":"High Alt. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/ham.2006.7.245","article-title":"Lipid profile, waist circumference, and body mass index in a high altitude population","volume":"7","author":"Mohanna","year":"2006","journal-title":"High Alt. Med. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Brito, J., Siques, P., L\u00f3pez, R., Romero, R., Le\u00f3n-Velarde, F., Flores, K., L\u00fcneburg, N., Hannemann, J., and B\u00f6ger, R.H. (2018). Long-term intermittent work at high altitude: Right heart functional and morphological status and associated cardiometabolic factors. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00248"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4161\/15384101.2014.991572","article-title":"mTOR coordinates protein synthesis, mitochondrial activity and proliferation","volume":"14","author":"Morita","year":"2015","journal-title":"Cell Cycle (Georgetown Tex.)"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20109","DOI":"10.1074\/jbc.M110.121699","article-title":"Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly","volume":"285","author":"Kaizuka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15461","DOI":"10.1074\/jbc.C200665200","article-title":"The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) Motif","volume":"278","author":"Nojima","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Dos","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","article-title":"mSin1 Is necessary for akt\/pkb phosphorylation, and its isoforms define three distinct mTORC2s","volume":"16","author":"Frias","year":"2006","journal-title":"Curr. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shi, F., and Collins, S. (2023). Regulation of mTOR signaling: Emerging role of cyclic nucleotide-dependent protein kinases and implications for cardiometabolic disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411497"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Hoeper","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.114.006977","article-title":"Pathophysiology and treatment of high-altitude pulmonary vascular disease","volume":"131","author":"Wilkins","year":"2015","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","article-title":"Hypoxic pulmonary vasoconstriction: From molecular mechanisms to medicine","volume":"151","author":"Wu","year":"2017","journal-title":"Chest"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"111476","DOI":"10.1016\/j.yexcr.2019.06.021","article-title":"Role of integrin-linked kinase in the hypoxia-induced phenotypic transition of pulmonary artery smooth muscle cells: Implications for hypoxic pulmonary hypertension","volume":"382","author":"Hou","year":"2019","journal-title":"Exp. Cell Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1152\/japplphysiol.00733.2004","article-title":"Hypoxic pulmonary vasoconstriction","volume":"98","author":"Moudgil","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccm.2006.11.010","article-title":"Pathology of pulmonary hypertension","volume":"28","author":"Tuder","year":"2007","journal-title":"Clin. Chest Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"H570","DOI":"10.1152\/ajpheart.01324.2007","article-title":"Mitochondrial metabolism, redox signaling, and fusion: A mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer","volume":"294","author":"Archer","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ham.2016.0031","article-title":"Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment","volume":"17","author":"Villafuerte","year":"2016","journal-title":"High Alt. Med. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mvr.2004.06.001","article-title":"Cellular and molecular mechanisms of pulmonary vascular remodeling: Role in the development of pulmonary hypertension","volume":"68","author":"Mandegar","year":"2004","journal-title":"Microvasc. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-0-387-75434-5_8","article-title":"Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling","volume":"618","author":"Stenmark","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"C1971","DOI":"10.1152\/ajpcell.2001.281.6.C1971","article-title":"HIF-1 expression in healing wounds: HIF-1\u03b1 induction in primary inflammatory cells by TNF-\u03b1","volume":"281","author":"Albina","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.resp.2010.08.007","article-title":"Hypoxia-induced changes in pulmonary and systemic vascular resistance: Where is the O2 sensor?","volume":"174","author":"Waypa","year":"2010","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1152\/japplphysiol.00103.2017","article-title":"Recent advances in oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction","volume":"123","author":"Strielkov","year":"2017","journal-title":"J. Appl. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Siques, P., Pena, E., Brito, J., and El Alam, S. (2021). Oxidative Stress, Kinase Activation, and Inflammatory Pathways Involved in Effects on Smooth Muscle Cells During Pulmonary Artery Hypertension Under Hypobaric Hypoxia Exposure. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.690341"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Urrutia, A.A., and Aragon\u00e9s, J. (2018). HIF oxygen sensing pathways in lung biology. Biomedicines, 6.","DOI":"10.3390\/biomedicines6020068"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-022-04770-4","article-title":"Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Babicheva, A., Makino, A., and Yuan, J.X.J. (2021). mTOR signaling in pulmonary vascular disease: Pathogenic role and therapeutic target. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042144"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1096\/fj.01-0658com","article-title":"Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) -dependent signaling","volume":"16","author":"Humar","year":"2002","journal-title":"FASEB J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1152\/japplphysiol.00715.2004","article-title":"Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation","volume":"98","author":"Gerasimovskaya","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1096\/fj.10-175018","article-title":"mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia","volume":"25","author":"Krymskaya","year":"2011","journal-title":"FASEB J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1096\/fj.12-222224","article-title":"mTOR and vascular remodeling in lung diseases: Current challenges and therapeutic prospects","volume":"27","author":"Goncharova","year":"2013","journal-title":"FASEB J."},{"key":"ref_43","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yexcr.2019.02.022","article-title":"Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt\/mTOR\/HIF-1 alpha signaling pathway","volume":"380","author":"Liu","year":"2019","journal-title":"Exp. Cell Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jamp.2019.1576","article-title":"Global Burden of Chronic Respiratory Diseases","volume":"33","author":"Viegi","year":"2020","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.12-2664","article-title":"Oxidative stress in COPD","volume":"144","author":"Kirkham","year":"2013","journal-title":"Chest"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-physiol-022516-034314","article-title":"Senescence in COPD and its comorbidities","volume":"79","author":"Barnes","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_51","first-page":"512","article-title":"Role of PI3K\/AKT\/mTOR signaling pathway and sirtuin genes in chronic obstructive pulmonary disease development","volume":"27","author":"Korytina","year":"2023","journal-title":"Vavilovskii Zh. Genet. Sel."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e93203","DOI":"10.1172\/jci.insight.93203","article-title":"mTOR pathway activation drives lung cell senescence and emphysema","volume":"3","author":"Houssaini","year":"2018","journal-title":"JCI Insight"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Yi, X., Li, T., Wei, X., and He, Z. (2022). Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1043474"},{"key":"ref_54","first-page":"3745","article-title":"[Effects of mTOR-Cdc42 signaling pathway on phagocytosis of alveolar macrophages in chronic obstructive pulmonary disease mice]","volume":"96","author":"Wang","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Uzun, A.B., Iliescu, M.G., Stanciu, L.-E., Ionescu, E.V., Ungur, R.A., Ciortea, V.M., Irsay, L., Motoa\u0219c\u0103, I., Popescu, M.N., and Popa, F.L. (2023). Effectiveness of Intermittent Hypoxia-Hyperoxia Therapy in Different Pathologies with Possible Metabolic Implications. Metabolites, 13.","DOI":"10.3390\/metabo13020181"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/JMN:21:1:57","article-title":"Plasma levels of nitric oxide and L-arginine in sleep apnea patients: Effects of nCPAP treatment","volume":"21","author":"Lavie","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.200608-1190PP","article-title":"Cardiovascular morbidity in obstructive sleep apnea: Oxidative stress, inflammation, and much more","volume":"177","author":"Gozal","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Garc\u00eda, E., Jaureguizar, A., Casitas, R., Garc\u00eda-Tovar, S., S\u00e1nchez-S\u00e1nchez, B., Zamarr\u00f3n, E., L\u00f3pez-Collazo, E., Garc\u00eda-R\u00edo, F., and Cubillos-Zapata, C. (2020). SMAD4 overexpression in patients with sleep apnoea may be associated with cardiometabolic comorbidities. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082378"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gong, H., Lyu, X., Dong, L., Tan, S., Li, S., Peng, J., Liu, Y., and Zhang, X. (2022). Obstructive sleep apnea impacts cardiac function in dilated cardiomyopathy patients through circulating exosomes. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.699764"},{"key":"ref_62","first-page":"1443","article-title":"p53 mediates PEDF-induced autophagy in human umbilical vein endothelial cells through sestrin2 signaling","volume":"20","author":"Chen","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2019.03.003","article-title":"Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship","volume":"72","author":"Wainwright","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/13510002.2021.1948774","article-title":"Sestrin2 in hypoxia and hypoxia-related diseases","volume":"26","author":"Che","year":"2021","journal-title":"Redox Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-019-0157-1","article-title":"mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress","volume":"2","author":"Ling","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9877053","DOI":"10.1155\/2021\/9877053","article-title":"Disturbances of the gut microbiota, sleep architecture, and mTOR signaling pathway in patients with severe obstructive sleep apnea-associated hypertension","volume":"2021","author":"Ko","year":"2021","journal-title":"Int. J. Hypertens."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/rccm.201207-1323CI","article-title":"High-altitude medicine","volume":"186","author":"West","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"111395","DOI":"10.1016\/j.exger.2021.111395","article-title":"Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice","volume":"151","author":"McNair","year":"2021","journal-title":"Exp. Gerontol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Flores, K., Siques, P., Brito, J., Ordenes, S., Arriaza, K., Pena, E., Le\u00f3n-Velarde, F., L\u00f3pez, R., de Pablo, \u00c1.L.L., and Arribas, S. (2020). Lower body weight in rats under hypobaric hypoxia exposure would lead to reduced right ventricular hypertrophy and increased AMPK activation. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00342"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/15353702221147557","article-title":"Weighted gene co-expression network analysis reveals the hub genes associated with pulmonary hypertension","volume":"248","author":"Wang","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ye, Y., Xu, Q., and Wuren, T. (2023). Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1162556"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"L354","DOI":"10.1152\/ajplung.00010.2002","article-title":"PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells","volume":"283","author":"Goncharova","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"29655","DOI":"10.1074\/jbc.M212770200","article-title":"A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets","volume":"278","author":"Arsham","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_74","first-page":"2860","article-title":"Neuroprotective effect of intermittent hypobaric hypoxia preconditioning on cerebral ischemia\/reperfusion in rats","volume":"13","author":"Yue","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1164\/rccm.202108-1808OC","article-title":"Daily exposure to mild intermittent hypoxia reduces blood pressure in male patients with obstructive sleep apnea and hypertension","volume":"205","author":"Panza","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_76","unstructured":"(2021, March 25). \u00abInstituto de Seguridad Laboral; Acerca del ISL\u00bb. Available online: www.isl.gob.cl."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/etm.2021.10706","article-title":"TFEC contributes to cardiac hypertrophy by inhibiting AMPK\/mTOR signaling","volume":"22","author":"Zhao","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cui, F., Hu, H.F., Guo, J., Sun, J., and Shi, M. (2020). The effect of autophagy on chronic intermittent hypobaric hypoxia ameliorating liver damage in metabolic syndrome rats. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00013"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/cjp.cjp_84_21","article-title":"Adenosine mono-phosphate-activated protein kinase-mammalian target of rapamycin signaling participates in the protective effect of chronic intermittent hypobaric hypoxia on vascular endothelium of metabolic syndrome rats","volume":"65","author":"Cui","year":"2022","journal-title":"Chin. J. Physiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e12523","DOI":"10.1111\/cob.12523","article-title":"Cardiometabolic risk factors in adults with normal weight obesity: A systematic review and meta-analysis","volume":"12","author":"Rakhmat","year":"2022","journal-title":"Clin. Obes."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCRESAHA.118.312669","article-title":"Sedentary Behavior, Exercise, and Cardiovascular Health","volume":"124","author":"Lavie","year":"2019","journal-title":"Circ. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.115.019351","article-title":"Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension","volume":"133","author":"Brittain","year":"2016","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011\u20132016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"702.e707","DOI":"10.1016\/j.amjmed.2017.12.046","article-title":"Diabetes mellitus associates with increased right ventricular afterload and remodeling in pulmonary arterial hypertension","volume":"131","author":"Whitaker","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e123611","DOI":"10.1172\/jci.insight.123611","article-title":"Human PAH is characterized by a pattern of lipid-related insulin resistance","volume":"4","author":"Hemnes","year":"2019","journal-title":"JCI Insight"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.7092","article-title":"Associations of weight gain from early to middle adulthood with major health outcomes later in life","volume":"318","author":"Zheng","year":"2017","journal-title":"JAMA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-139-4-200308190-00007","article-title":"Obesity: Associations with acute mountain sickness","volume":"139","author":"Chase","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"100599","DOI":"10.1016\/j.cpcardiol.2020.100599","article-title":"Obesity, Systemic Hypertension, and Pulmonary Hypertension: A Tale of Three Diseases","volume":"46","author":"Wahab","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-118-8-199304150-00003","article-title":"Acute mountain sickness in a general tourist population at moderate altitudes","volume":"118","author":"Honigman","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/ham.2015.0084","article-title":"Increased cardiometabolic risk and worsening hypoxemia at high altitude","volume":"17","author":"Miele","year":"2016","journal-title":"High Alt. Med. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"160096","DOI":"10.1183\/16000617.0096-2016","article-title":"Acute high-altitude sickness","volume":"26","author":"Luks","year":"2017","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2002258","DOI":"10.1183\/13993003.02258-2020","article-title":"Sleep-related breathing disorders and pulmonary hypertension","volume":"57","author":"Adir","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.ijo.0802726","article-title":"Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude","volume":"28","author":"Rebollar","year":"2004","journal-title":"Int. J. Obes."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"E877","DOI":"10.1152\/ajpendo.00626.2010","article-title":"Regulation of HIF-1{\u03b1} activity in adipose tissue by obesity-associated factors: Adipogenesis, insulin, and hypoxia","volume":"300","author":"He","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/db06-0911","article-title":"Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation","volume":"56","author":"Hosogai","year":"2007","journal-title":"Diabetes"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Perrotta, F., Nigro, E., Mollica, M., Costigliola, A., D\u2019Agnano, V., Daniele, A., Bianco, A., and Guerra, G. (2019). Pulmonary hypertension and obesity: Focus on adiponectin. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040912"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrg3575","article-title":"Systems genetics approaches to understand complex traits","volume":"15","author":"Civelek","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Engin, A. (2017). Adiponectin-resistance in obesity. Advances in Experimental Medicine and Biology, Springer International Publishing.","DOI":"10.1007\/978-3-319-48382-5_18"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(05)66585-3","article-title":"\u201cVasocrine\u201d signalling from perivascular fat: A mechanism linking insulin resistance to vascular disease","volume":"365","author":"Yudkin","year":"2005","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1183\/09031936.00000508","article-title":"Insulin resistance in pulmonary arterial hypertension","volume":"33","author":"Zamanian","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.00030312","article-title":"A potential role for insulin resistance in experimental pulmonary hypertension","volume":"41","author":"West","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.acvd.2020.01.003","article-title":"Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms","volume":"113","author":"Arnaud","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/crj.13336","article-title":"Association between insulin resistance and BMI with FEV1 in non-hypoxemic COPD out-patients","volume":"15","author":"Zuberi","year":"2021","journal-title":"Clin. Respir. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/092986709787002853","article-title":"Endothelial dysfunction in diabetes: From mechanisms to therapeutic targets","volume":"16","author":"Potenza","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_105","first-page":"e19710","article-title":"Insulin resistance in pulmonary arterial hypertension, is it a novel disease modifier?","volume":"3","author":"Naderi","year":"2014","journal-title":"Res. Cardiovasc. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1463-1326.2000.00092.x","article-title":"Insulin action in vascular endothelium: Potential mechanisms linking insulin resistance with hypertension","volume":"2","author":"Montagnani","year":"2000","journal-title":"Diabetes Obes. Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.numecd.2018.09.005","article-title":"Caloric restriction attenuates aging-induced cardiac insulin resistance in male Wistar rats through activation of PI3K\/Akt pathway","volume":"29","author":"Granado","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000070937.52035.25","article-title":"Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury","volume":"107","author":"Kubota","year":"2003","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/01.HYP.0000147559.10261.a7","article-title":"Impairment of PI3-K\/Akt pathway underlies attenuated endothelial function in Aorta of Type 2 diabetic mouse model","volume":"44","author":"Kobayashi","year":"2004","journal-title":"Hypertension"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2009.11.038","article-title":"Vascular insulin resistance in prehypertensive rats: Role of PI3-kinase\/Akt\/eNOS signaling","volume":"628","author":"Li","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"ref_112","first-page":"1","article-title":"Emerging role of Akt kinase\/protein kinase B signaling in pathophysiology of diabetes and its complications","volume":"54","author":"Komers","year":"2005","journal-title":"Physiol. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/cvr\/cvs004","article-title":"T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells","volume":"93","author":"Philippova","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/MCB.22.4.1016-1026.2002","article-title":"Molecular mechanism of insulin-induced degradation of insulin receptor substrate","volume":"22","author":"Zhande","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1074\/jbc.M208518200","article-title":"Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-Kinase\/Akt signaling pathway by disrupting the association of IRS-1\/IRS-2 with the insulin receptor","volume":"278","author":"Wick","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1083\/jcb.200408161","article-title":"Balancing Akt with S6K: Implications for both metabolic diseases and tumorigenesis","volume":"167","author":"Manning","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metab."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yoon, M.S. (2017). The role of mammalian target of Rapamycin (mTOR) in insulin signaling. Nutrients, 9.","DOI":"10.3390\/nu9111176"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","article-title":"Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process","volume":"165","author":"Roshan","year":"2019","journal-title":"Biochimie"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2011.11.018","article-title":"National Kidney Foundation\u2019s Kidney Early Evaluation Program (KEEP) annual data report 2011: Executive summary","volume":"59","author":"Vassalotti","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.coph.2012.12.006","article-title":"Therapy of obese patients with cardiovascular disease","volume":"13","author":"Jindal","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1113\/expphysiol.2011.062257","article-title":"Different patterns of pulmonary vascular disease induced by type 1 diabetes and moderate hypoxia in rats","volume":"97","author":"Menendez","year":"2012","journal-title":"Exp. Physiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1042\/BST20130018","article-title":"Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2)","volume":"41","author":"Destefano","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2174\/1389450123666220111115528","article-title":"Targeting mTOR signaling in type 2 diabetes mellitus and diabetes complications","volume":"23","author":"Yang","year":"2022","journal-title":"Curr. Drug Targets"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/nm1004-1049","article-title":"Nutrient sensor links obesity with diabetes risk","volume":"10","author":"Patti","year":"2004","journal-title":"Nat. Med."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Karar, J., and Maity, A. (2011). PI3K\/AKT\/mTOR pathway in angiogenesis. Front. Mol. Neurosci., 4.","DOI":"10.3389\/fnmol.2011.00051"},{"key":"ref_129","first-page":"5947859","article-title":"Akt\/mTOR role in human foetoplacental vascular insulin resistance in diseases of pregnancy","volume":"2017","author":"Silva","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/HYPERTENSIONAHA.122.19857","article-title":"Targeting Endothelial ENO1 (Alpha-Enolase)-PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension","volume":"80","author":"Shi","year":"2023","journal-title":"Hypertension"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-018-0899-2","article-title":"Obesity and pulmonary hypertension","volume":"20","author":"Ayinapudi","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCRESAHA.115.308178","article-title":"Protective roles of endothelial AMP-activated protein kinase against hypoxia-induced pulmonary hypertension in mice","volume":"119","author":"Omura","year":"2016","journal-title":"Circ. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0002-9149(96)00159-2","article-title":"Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men","volume":"77","author":"Assmann","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201001-0007OC","article-title":"Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension","volume":"182","author":"Heresi","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/HCO.0000000000000862","article-title":"Triglycerides and cardiovascular disease","volume":"36","author":"Esan","year":"2021","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpeds.2012.04.008","article-title":"Dyslipidemia without obesity in indigenous argentinean children living at high altitude","volume":"161","author":"Hirschler","year":"2012","journal-title":"J. Pediatr."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ijcp.12756","article-title":"Cardiometabolic risk factors in native populations living at high altitudes","volume":"70","author":"Hirschler","year":"2016","journal-title":"Int. J. Clin. Pract."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/678510","article-title":"Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia","volume":"4","author":"Irwin","year":"2014","journal-title":"Pulm. Circ."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Mitra, A.K., Bhuiyan, A.R., and Jones, E.A. (2021). Association and risk factors for obstructive sleep apnea and cardiovascular diseases: A systematic review. Diseases, 9.","DOI":"10.3390\/diseases9040088"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"14799731221133387","DOI":"10.1177\/14799731221133387","article-title":"Computed tomography-based body composition measures in COPD and their association with clinical outcomes: A systematic review","volume":"19","author":"Nicholson","year":"2022","journal-title":"Chronic Respir. Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/13813450312331342319","article-title":"Hypertriglyceridemia associated with decreased post-heparin plasma hepatic triglyceride lipase activity in hypoxic rats","volume":"111","author":"Muratsubaki","year":"2003","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.beem.2010.08.011","article-title":"Metabolic consequences of intermittent hypoxia: Relevance to obstructive sleep apnea","volume":"24","author":"Drager","year":"2010","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1152\/physiolgenomics.00293.2005","article-title":"Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1\u03b1","volume":"25","author":"Li","year":"2006","journal-title":"Physiol. Genom."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/ham.2013.1134","article-title":"Plasma and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: Changes in metabolic pathways","volume":"15","author":"Siques","year":"2014","journal-title":"High Alt. Med. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese Rats: Possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"R1198","DOI":"10.1152\/ajpregu.00262.2014","article-title":"Overnutrition, mTOR signaling, and cardiovascular diseases","volume":"307","author":"Jia","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1042\/bst0320088","article-title":"Regulation of lipoprotein trafficking in the kidney: Role of inflammatory mediators and transcription factors","volume":"32","author":"Ruan","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.HYP.0000184653.75036.d5","article-title":"Lipid accumulation and transforming growth factor-\u03b2 upregulation in the kidneys of rats administered angiotensin II","volume":"46","author":"Saito","year":"2005","journal-title":"Hypertension"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.biocel.2013.07.007","article-title":"Phospho-GSK-3\u03b2 is involved in the high-glucose-mediated lipid deposition in renal tubular cells in diabetes","volume":"45","author":"Liu","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_152","first-page":"6","article-title":"HMGB1\/SREBP-1 mediated IFN-gamma-induced lipid deposition in mouse mesangial cells","volume":"29","author":"Zhang","year":"2013","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"C760","DOI":"10.1152\/ajpcell.00352.2012","article-title":"IFN-\u03b3 induces lipogenesis in mouse mesangial cells via the JAK2\/STAT1 pathway","volume":"304","author":"Hao","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.yexcr.2013.06.013","article-title":"Phospho-mTOR: A novel target in regulation of renal lipid metabolism abnormality of diabetes","volume":"319","author":"Hao","year":"2013","journal-title":"Exp. Cell Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejphar.2015.09.031","article-title":"miR-100 suppresses mTOR signaling in hypoxia-induced pulmonary hypertension in rats","volume":"765","author":"Wang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yexcr.2015.06.006","article-title":"Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice","volume":"336","author":"Wang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2013121332","article-title":"SREBP-1 mediates angiotensin II-induced TGF-\u03b21 upregulation and glomerular fibrosis","volume":"26","author":"Wang","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"115101","DOI":"10.1016\/j.jep.2022.115101","article-title":"Zexie Tang targeting FKBP38\/mTOR\/SREBPs pathway improves hyperlipidemia","volume":"290","author":"Xie","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2147\/DDDT.S409373","article-title":"Metformin: A review of potential mechanism and therapeutic utility beyond diabetes","volume":"17","author":"Dutta","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.freeradbiomed.2015.09.012","article-title":"Autophagy protects intestinal epithelial cells against deoxynivalenol toxicity by alleviating oxidative stress via IKK signaling pathway","volume":"89","author":"Tang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Vi\u0161nji\u0107, D., Lali\u0107, H., Dembitz, V., Tomi\u0107, B., and Smoljo, T. (2021). AICAr, a widely used AMPK activator with important AMPK-independent effects: A systematic review. Cells, 10.","DOI":"10.3390\/cells10051095"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"eaav3249","DOI":"10.1126\/scisignal.aav3249","article-title":"AMPK directly activates mTORC2 to promote cell survival during acute energetic stress","volume":"12","author":"Kazyken","year":"2019","journal-title":"Sci. Signal."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/hq0701.092104","article-title":"Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin","volume":"21","author":"Mann","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-8-15","article-title":"Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice","volume":"8","author":"Paddenberg","year":"2007","journal-title":"Respir. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13020-022-00568-w","article-title":"Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension","volume":"17","author":"Yu","year":"2022","journal-title":"Chin. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as \u201ccurecumin\u201d: From kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_172","first-page":"3185","article-title":"Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt\/mTOR signaling","volume":"29","author":"Johnson","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Salehi, B., Mishra, A.P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P.V.T., Martins, N., and Sharifi-Rad, J. (2018). Resveratrol: A double-edged sword in health benefits. Biomedicines, 6.","DOI":"10.3390\/biomedicines6030091"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"116748","DOI":"10.1016\/j.lfs.2019.116748","article-title":"Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K\/AKT\/mTOR pathway","volume":"233","author":"Guan","year":"2019","journal-title":"Life Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"25414","DOI":"10.1074\/jbc.M113.460287","article-title":"MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCRESAHA.114.301633","article-title":"MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Alastalo","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm.3040","article-title":"An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1165\/rcmb.2014-0337OC","article-title":"Peroxisome Proliferator-Activated Receptor \u03b3 and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling","volume":"54","author":"Kang","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.114.007405","article-title":"Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p","volume":"130","author":"Sharma","year":"2014","journal-title":"Circulation"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Hu, Y.Z., Li, Q., Wang, P.F., Li, X.P., and Hu, Z.L. (2023). Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1140813"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.biopha.2018.11.058","article-title":"MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension","volume":"109","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40164-020-00182-2","article-title":"miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR","volume":"9","author":"Lin","year":"2020","journal-title":"Exp. Hematol. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/20\/11023\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:12:50Z","timestamp":1760112770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/20\/11023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":184,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ijms252011023"],"URL":"https:\/\/doi.org\/10.3390\/ijms252011023","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}